https://drugnews.com.tw/articles/2026-10-15-sandoz-celltrion-biosimilar-profit-capacity-en.html Drugnews｜藥時事 en 2026-10-15T00:00:00.000Z Celltrion's Record Profit Starts in Its Own Factories https://drugnews.com.tw/articles/2026-10-15-sandoz-celltrion-biosimilar-profit-capacity.html Drugnews｜藥時事 zh-tw 2026-10-15T00:00:00.000Z Celltrion 獲利破紀錄，贏在自己的工廠 https://drugnews.com.tw/articles/2026-10-14-eloratzp-weight-loss-tolerability-persistence-en.html Drugnews｜藥時事 en 2026-10-14T00:00:00.000Z The Two-Drug Bet in Weight-Loss Injections https://drugnews.com.tw/articles/2026-10-14-eloratzp-weight-loss-tolerability-persistence.html Drugnews｜藥時事 zh-tw 2026-10-14T00:00:00.000Z 瘦瘦針的雙藥賭注